Asthma is a chronic respiratory disease. It is an inflammatory condition of the lower airways that affects around 275–300 million people globally and 25 to 30 million people in India. It can attack all age groups and is characterised by recurrent attacks of breathlessness, wheezing and coughing, which may vary from person to person in severity and frequency. It is caused by inflammation of air passages, hypersensitivity to allergens, pulmonary oedema and congestion of lungs. This case report is an evidence of successful treatment of sub-acute exacerbations of bronchial asthma by using homoeopathic medicine based on acute totality of the case. The case of a 32-year-old woman with bronchial asthma is reported here who was treated with Blatta orientalis 30C. All investigations and pulmonary function tests (spirometry) indicated the diagnosis to be bronchial asthma with moderate obstruction of small airways. After case taking, Blatta orientalis 30C was prescribed, following which, after 6 months of treatment, patient felt better in all aspects with reduction in the number of asthma attacks and marked improvement in Elizabeth Juniper's Asthma Control Questionnaire Score and other investigations.

Urinary incontinence is one of the priority health issue recognized by World Health Organisation. Urinary incontinence is defined as "a condition in which involuntary loss of urine is objectively demonstrable." The present hospital-based crosssectional study was conducted from November 2018 to January 2019. Total 322 women aged above 18 years were screened, who attended the hospital OPD of Homoeopathy University, Saipura, Sanganer, Jaipur. They were subjected to set of questionnaire related to urinary incontinence. Among the 322 participants the prevalence of urinary incontinence was 55.3% (95% confidence interval: 0.50-0.60%). The most common subtype was stress incontinence followed by mixed incontinence. The adjusted analysis revealed that women with middle age group (33-48 years) had more incidence of urinary incontinence (p value=0.000; χ2=60.802) and urinary incontinence showed an increasing trend with increasing parity with the p value = 0.002 (χ2=9.297).

Background Bronchial asthma is a globally significant non-communicable disease with major public health consequences for both children and adults, including high morbidity, and relatively low mortality compared with other chronic diseases. It is a chronic disorder that enables the patient to take lifelong medications including bronchodilators. Aim: This study was undertaken to ascertain the effects of Blatta orientalis in potency on the treatment of bronchial asthma assessed by spirometry and Asthma Control Questionnaire (ACQ) Score. Method A prospective, non-randomised, open-label, observational study was conducted at Dr. MPK Homoeopathic Medical College, Hospital & Research Centre, Jaipur, Rajasthan, from 2015 to 2016. Patients between 5 and 80 years of age suffering from dyspnoea, cough with expectoration and wheezing were screened. The convenience sampling technique was used to enrol 120 patients, after fulfilling the inclusion and exclusion criteria of the study. The patients of Bronchial asthma were treated with Blatta orientalis in potency for 6 months. Patients were diagnosed and assessed on the basis of the ACQ Score by Elizabeth Junipers and spirometry findings. Blatta orientalis was prescribed to all patients in increasing potency from 30C. The paired t-test is applied to calculate the statistical significance of the study. Result Out of 120 patients, 100 had completed the study with follow-up of 6 months. A significant difference was found in pre- and post-treatment spirometry—that is, forced expiratory volume in 1 second/forced vital capacity (FEV1/FVC) ratio—from baseline to 6 months (mean ± standard deviation [SD]: –10.27 ± 4.95; 95% confidence interval [CI]: –11.25 to –9.28; p = 0.00001). Also, significant difference was seen in the ACQ Score from baseline to 6 months (mean ± SD: 19.44 ± 8.69; 95% CI: 17.71–21.16; p = 0.00001). Conclusion The study findings are encouraging enough to prescribe Blatta orientalis in potency in cases of bronchial asthma. Further systematic replication is required to be conducted as randomised controlled trials with long-term follow-ups for definite conclusions.

No abstract